Editas Medicine Inc (EDIT)
1.31
-0.03
(-2.24%)
USD |
NASDAQ |
Dec 20, 16:00
1.33
+0.02
(+1.53%)
After-Hours: 20:00
Editas Medicine Price to Book Value: 0.6157 for Dec. 20, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
Ionis Pharmaceuticals Inc | 8.495 |
EyePoint Pharmaceuticals Inc | 2.222 |
Cassava Sciences Inc | 0.6814 |
Adverum Biotechnologies Inc | 0.6842 |
Regenxbio Inc | 1.254 |
Price to Book Value Related Metrics
PS Ratio | 1.742 |
Price | 1.31 |
Earnings Yield | -195.4% |
Market Cap | 108.14M |